Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 3 (2006), Issue 5 (May)

1. Cervical cancer.
   Obstet Gynecol, 107(5): 1152-61. [Abstract] [Full-text]
2. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
   Obstet Gynecol, 107(5): 997-1005. [Abstract] [Full-text]
3. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors.
   Br J Cancer, 94(9): 1253-62. [Abstract] [Full-text]
4. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
   Int J Radiat Oncol Biol Phys, 65(2): 624-30. [Abstract] [Full-text]
5. Interfractional dose variation during intensity-modulated radiation therapy for cervical cancer assessed by weekly CT evaluation.
   Int J Radiat Oncol Biol Phys, 65(2): 617-23. [Abstract] [Full-text]
6. Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix.
   Int J Radiat Oncol Biol Phys, 65(2): 388-97. [Abstract] [Full-text]
7. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
   Int J Cancer, 119(3): 615-23. [Abstract] [Full-text]
8. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report.
   Gynecol Oncol, 101(2): 367-70. [Abstract] [Full-text]
9. Pelvic radiation necrosis and osteomyelitis following chemoradiation for advanced stage vulvar and cervical carcinoma.
   Gynecol Oncol, 101(2): 349-52. [Abstract] [Full-text]
10. Adenocarcinoma of the uterine cervix with choriocarcinomatous metastasis.
    Gynecol Oncol, 101(2): 346-8. [Abstract] [Full-text]
11. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
    Gynecol Oncol, 101(2): 296-304. [Abstract] [Full-text]
12. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?
    Gynecol Oncol, 101(2): 244-9. [Abstract] [Full-text]
13. Ovarian metastasis in carcinoma of the uterine cervix.
    Gynecol Oncol, 101(2): 234-7. [Abstract] [Full-text]
14. A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis.
    Gynecol Oncol, 101(2): 250-4. [Abstract] [Full-text]
15. Antitumor therapeutic effects of e7 subunit and DNA vaccines in an animal cervical cancer model: antitumor efficacy of e7 therapeutic vaccines is dependent on tumor sizes, vaccine doses, and vaccine delivery routes.
    DNA Cell Biol, 25(5): 277-86. [Abstract] [Full-text]
16. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    PLoS Med, 3(5): e138. [Abstract] [Full-text]
17. p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.
    Gynecol Oncol, 101(3): 487-94. [Abstract] [Full-text]
18. CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer.
    Gynecol Oncol, 101(3): 503-6. [Abstract] [Full-text]
19. Persistent HPV infection after conization in patients with negative margins.
    Gynecol Oncol, 101(3): 418-22. [Abstract] [Full-text]
20. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
    Gynecol Oncol, 101(3): 411-7. [Abstract] [Full-text]
21. Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
    Gynecol Oncol, 101(3): 455-63. [Abstract] [Full-text]
22. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
    Gynecol Oncol, 101(3): 441-4. [Abstract] [Full-text]
23. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
    Gynecol Oncol, 101(3): 429-35. [Abstract] [Full-text]
24. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Gynecol Oncol, 101(3): 398-402. [Abstract] [Full-text]

© 2004-2008 Cervical Cancer Research Today. All Rights Reserved.